The North America blood plasma market is witnessing significant expansion, driven by rising demand for plasma-derived therapies, increasing prevalence of chronic and rare diseases, and advancements in plasma collection technologies. Blood plasma, the liquid component of blood, plays a crucial role in treating conditions such as immunodeficiency disorders, hemophilia, and neurological diseases....